Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.80%
#2 Mubarak Mubarak +36.45%
#3 Pons Pons +36.32%
#4 Starpower Starpower +34.59%
#5 Bitway Bitway +31.78%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.19%
#7 TENDIES TENDIES +25.97%
#8 Ocean Protocol Ocean Protocol +24.85%
#9 SkyAI SkyAI +24.01%
#10 StonkBroker StonkBroker +21.30%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
General Biologicals Corporation General Biologicals Corporation

General Biologicals Corporation

4117
Classement en actions #29236
General Biologicals Corporation (GBC) is a company dedicated to the research,... General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.
Prix de l'action
$0.31640033
Capitalisation boursière
$22.25M
Changement (1 jour)
-3.40%
Changement (1 an)
-36.80%
Pays
TW
Échange General Biologicals Corporation (4117)

Catégorie

Healthcare
Le prix 4117 avec la capitalisation boursière de B
General Biologicals Corporation General Biologicals Corporation
4117
$0.31640033
Capitalisation boursière de General Biologicals Corporation(4117)
Capitalisation boursière: $22.25M
En August 2026, General Biologicals Corporation a une capitalisation boursière de $22.25M. Cela fait de General Biologicals Corporation la 29236th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de General Biologicals Corporation du 2007 au 2026
4117 par rapport au top 5 des plus populaires stocks
Prix pour 4117 L’actif B La capitalisation boursière de B Résultats
General Biologicals Corporation General Biologicals Corporation
$75,420.69 $22.25M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.304T +23,837,007.31%
General Biologicals Corporation General Biologicals Corporation
$66,127.60 $22.25M
Apple Inc. Apple Inc.
AAPL
$4.650T +20,899,879.66%
General Biologicals Corporation General Biologicals Corporation
$59,088.07 $22.25M
Alphabet Inc. Alphabet Inc.
GOOG
$4.155T +18,674,997.25%
General Biologicals Corporation General Biologicals Corporation
$51,150.94 $22.25M
Microsoft Corporation Microsoft Corporation
MSFT
$3.597T +16,166,425.67%
General Biologicals Corporation General Biologicals Corporation
$40,443.67 $22.25M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.844T +12,782,337.73%